Intestinal Toxicity Assessment with Patient-Derived Organoids
Dr. Martin Stahl describes the use of patient-derived intestinal organoids to assess the toxicity of potential therapeutic compounds and study barrier function in a human-specific model system.
Featured Webinars
Turning Innovative Features Into Practical Benefits Within the Buxco Nose-Only Rodent Inhalation System
Thursday, September 28, 2023
Sponsors: Data Sciences International, Harvard Bioscience, Inc.
Advertisement
